Proteomics analysis of serum extracellular vesicle identifies UCHL1 as a potential therapeutic target for high grade serous ovarian cancer

No abstract is available for this paper.

• Publication year

  2025

• Venue

  British Journal of Cancer

• Publication date

  2025-11-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41416-025-03244-6PMID 41193854PMCID PMC12819396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small molecule inhibition of ubiquitin C-terminal hydrolase L1 alters cell metabolism proteins and exerts anti- or pro-tumorigenic effects contingent upon chemosensitivity status in high grade serous ovarian cancer

  2025cited by this paper
• The revelation of UCHL1 in malignant epithelial cells of TNBC reinforcing cisplatin resistance by modulating ferroptosis based on single-cell transcriptome data

  2025cited by this paper
• Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer

  2024cited by this paper
• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2024cited by this paper
• UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas

  2024cited by this paper
• Estrogen receptor beta expression and role in cancers.

  2024cited by this paper
• Ubiquitin C-terminal hydrolase L1 is a regulator of tumor growth and metastasis in double-negative prostate cancer.

  2024cited by this paper
• Osteopontin: A Key Multifaceted Regulator in Tumor Progression and Immunomodulation

  2024cited by this paper
• Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

  2024cited by this paper
• Systematic Multiomic Analysis of PKHD1L1 Gene Expression and Its Role as a Predicting Biomarker for Immune Cell Infiltration in Skin Cutaneous Melanoma and Lung Adenocarcinoma

  2023cited by this paper
• Extracellular vesicles targeting tumor microenvironment in ovarian cancer.

  2023cited by this paper
• Targeting carcinoma‐associated mesothelial cells with antibody–drug conjugates in ovarian carcinomatosis

  2023cited by this paper
• Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection

  2023cited by this paper
• Identifying high-grade serous ovarian carcinoma–specific extracellular vesicles by polyketone-coated nanowires

  2023cited by this paper
• Characteristics of Extracellular Vesicles from a High-Grade Serous Ovarian Cancer Cell Line Derived from a Platinum-Resistant Patient as a Potential Tool for Aiding the Prediction of Responses to Chemotherapy

  2023cited by this paper
• UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.

  2023cited by this paper
• Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer

  2023influential reference
• Ubiquitin C‑terminal hydrolase‑L1: A new cancer marker and therapeutic target with dual effects (Review)

  2023cited by this paper
• Estrogen promotes Epithelial ovarian cancer cells proliferation via down-regulating expression and activating phosphorylation of PTEN.

  2023cited by this paper
• Osteopontin and Cancer: Insights into Its Role in Drug Resistance

  2023cited by this paper
• Estrogens, Estrogen Receptors and Tumor Microenvironment in Ovarian Cancer

  2023cited by this paper
• New perspectives in cancer immunotherapy: targeting IL-6 cytokine family

  2023cited by this paper
• Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer

  2023cited by this paper
• Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer

  2023cited by this paper
• Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations

  2022cited by this paper
• Mass Dynamics 2.0: An improved modular web-based platform for accelerated proteomics insight generation and decision making

  2022influential reference
• Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer

  2022cited by this paper
• Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq

  2022cited by this paper
• UCHL1 promotes cancer stemness in triple-negative breast cancer.

  2022cited by this paper
• The Role of MARCKS in Metastasis and Treatment Resistance of Solid Tumors

  2022cited by this paper
• Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer

  2022cited by this paper
• Cancer treatment and survivorship statistics, 2022

  2022cited by this paper
• SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer

  2022cited by this paper
• Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion

  2022cited by this paper
• Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian Cancer

  2022cited by this paper
• Extracellular vesicles derived from ascitic fluid enhance growth and migration of ovarian cancer cells

  2021cited by this paper
• Mass Dynamics 1.0: A streamlined, web-based environment for analyzing, sharing and integrating Label-Free Data

  2021influential reference
• Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer

  2021cited by this paper
• Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence

  2021cited by this paper
• The reactome pathway knowledgebase 2022

  2021cited by this paper
• UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology

  2021cited by this paper
• Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response

  2021cited by this paper
• The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis

  2021cited by this paper
• A pan-cancer analysis of the oncogenic role of secreted phosphoprotein 1 (SPP1) in human cancers

  2021cited by this paper
• Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells

  2021cited by this paper
• Deubiquitinase UCHL1 Maintains Protein Homeostasis through the PSMA7–APEH–Proteasome Axis in High-grade Serous Ovarian Carcinoma

  2021cited by this paper
• A single-cell landscape of high-grade serous ovarian cancer

  2020cited by this paper
• The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase

  2020cited by this paper
• Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression

  2020cited by this paper
• Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis

  2019cited by this paper
• Correlation of OPN gene expression with proliferation and apoptosis of ovarian cancer cells and prognosis of patients

  2019cited by this paper
• Ultrasensitive detection of circulating exosomes with a 3D-nanopatterned microfluidic chip

  2019cited by this paper
• Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis

  2019cited by this paper
• The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects

  2019cited by this paper
• Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas

  2019cited by this paper
• GENT2: an updated gene expression database for normal and tumor tissues

  2019cited by this paper
• Inhibition of UCH-L1 Deubiquitinating Activity with Two Forms of LDN-57444 Has Anti-Invasive Effects in Metastatic Carcinoma Cells

  2019cited by this paper
• Comparison of methods to isolate proteins from extracellular vesicles for mass spectrometry-based proteomic analyses.

  2019cited by this paper
• Exosomes promote pre-metastatic niche formation in ovarian cancer

  2019cited by this paper
• Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression

  2019cited by this paper
• 4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer

  2019cited by this paper
• Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis

  2019cited by this paper
• Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary

  2019cited by this paper
• Ovarian cancer circulating extracelluar vesicles promote coagulation and have a potential in diagnosis: an iTRAQ based proteomic analysis

  2019cited by this paper
• Ubiquitin C‐terminal hydrolase‐L1 has prognostic relevance and is a therapeutic target for high‐grade neuroendocrine lung cancers

  2019cited by this paper
• Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity

  2019cited by this paper
• The deubiquitinating enzyme UCHL1 negatively regulates the immunosuppressive capacity and survival of multipotent mesenchymal stromal cells

  2018cited by this paper
• C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes

  2018cited by this paper
• Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

  2018cited by this paper
• Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics.

  2018cited by this paper
• High Expression of Ubiquitin C-terminal Hydrolase L1 Is Associated With Poor Prognosis in Endometrial Cancer Patients

  2018cited by this paper
• UCH‐L1 promotes invasion of breast cancer cells through activating Akt signaling pathway

  2018cited by this paper
• Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins

  2018cited by this paper
• Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression.

  2017cited by this paper
• Ovarian cancer: Novel molecular aspects for clinical assessment.

  2017cited by this paper
• Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value

  2017cited by this paper
• QuPath: Open source software for digital pathology image analysis

  2017influential reference
• UCH‐L1‐containing exosomes mediate chemotherapeutic resistance transfer in breast cancer

  2017cited by this paper
• MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis

  2016cited by this paper
• Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers

  2016cited by this paper
• Versatile roles of extracellular vesicles in cancer.

  2016cited by this paper
• Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.

  2016cited by this paper
• Fast and sensitive total protein and Peptide assays for proteomic analysis.

  2015cited by this paper
• High‐resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers

  2015cited by this paper
• Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation

  2015influential reference
• The stromal genome heterogeneity between breast and prostate tumors revealed by a comparative transcriptomic analysis

  2015cited by this paper
• In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.

  2014cited by this paper
• Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis

  2013cited by this paper
• Characterization and proteomic analysis of ovarian cancer-derived exosomes.

  2013cited by this paper
• UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance

  2013cited by this paper
• Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components

  2013cited by this paper
• Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression

  2013cited by this paper
• Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation

  2012cited by this paper
• Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer.

  2012cited by this paper
• ExoCarta as a resource for exosomal research

  2012cited by this paper
• Transforming growth factor‐beta‐induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells

  2011cited by this paper
• Significance of PGP9.5 expression in cancer-associated fibroblasts for prognosis of colorectal carcinoma.

  2010cited by this paper
• Proteomics Analysis of A33 Immunoaffinity-purified Exosomes Released from the Human Colon Tumor Cell Line LIM1215 Reveals a Tissue-specific Protein Signature*

  2009cited by this paper
• Silencing of the UCHL1 gene in human colorectal and ovarian cancers

  2006cited by this paper
• The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.

  2002cited by this paper

• No citing papers are available for this paper.